Triumph Capital Management Ishares Biotechnology ETF Transaction History
Triumph Capital Management
- $234 Million
- Q1 2024
A detailed history of Triumph Capital Management transactions in Ishares Biotechnology ETF stock. As of the latest transaction made, Triumph Capital Management holds 3,779 shares of IBB stock, worth $514,699. This represents 0.22% of its overall portfolio holdings.
Number of Shares
3,779
Previous 3,863
2.17%
Holding current value
$514,699
Previous $524,000
1.15%
% of portfolio
0.22%
Previous 0.23%
Shares
9 transactions
Others Institutions Holding IBB
# of Institutions
986Shares Held
37.8MCall Options Held
1.81MPut Options Held
8.71M-
Bank Of America Corp Charlotte, NC7.63MShares$1.04 Billion0.1% of portfolio
-
Goldman Sachs Group Inc New York, NY3.21MShares$438 Million0.08% of portfolio
-
Morgan Stanley New York, NY2.7MShares$368 Million0.03% of portfolio
-
Citigroup Inc2.59MShares$352 Million0.24% of portfolio
-
Jpmorgan Chase & CO New York, NY1.61MShares$219 Million0.02% of portfolio